LeMaitre Vascular, Inc. (LMAT) Revenue, Earnings & Financial Statements
$76.10NASDAQ: LMATMarket Cap $1.74B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
LeMaitre Vascular, Inc. most recently reported annual revenue of $250.0M, net profit of $58.0M. Revenue grew at an average annual rate of 14.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
LeMaitre Vascular, Inc.: Revenue rose from $89.0M in 2016 to $250.0M in 2025, a change of +180.9% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 18.3% to 27.2%, a shift of +8.9 percentage points; the most recent year shows net profit of $58.0M.
Income Statement — 10 Years (USD millions)
Metric
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
$89.0M
$101.0M
$106.0M
$117.0M
$129.0M
$154.0M
$162.0M
$193.0M
$220.0M
$250.0M
Operating Expenses
$73.0M
$80.0M
$77.0M
$96.0M
$101.0M
$118.0M
$135.0M
$157.0M
$168.0M
$182.0M
Operating Profit
$16.0M
$21.0M
$28.0M
$21.0M
$29.0M
$36.0M
$27.0M
$37.0M
$52.0M
$68.0M
Operating Margin
18.3%
20.9%
26.7%
18.1%
22.3%
23.6%
16.6%
19.0%
23.8%
27.2%
Other Income
$0
$0
$0
$0
−$1.0M
−$2.0M
$1.0M
$3.0M
$5.0M
$7.0M
Interest
$0
$0
$0
$0
$1.0M
$2.0M
$0
$0
$0
$5.0M
Depreciation
$4.0M
$4.0M
$4.0M
$5.0M
$8.0M
$11.0M
$9.0M
$10.0M
$10.0M
$10.0M
Profit Before Tax
$16.0M
$21.0M
$28.0M
$22.0M
$27.0M
$34.0M
$27.0M
$39.0M
$57.0M
$75.0M
Tax rate (%)
34.8%
18.6%
19.3%
17.3%
22.4%
21.5%
24.9%
23.7%
22.6%
23.2%
Net Profit
$11.0M
$17.0M
$23.0M
$18.0M
$21.0M
$27.0M
$21.0M
$30.0M
$44.0M
$58.0M
EPS
$0.55
$0.86
$1.13
$0.88
$1.04
$1.25
$0.93
$1.34
$1.93
$2.52
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$49.0M
$53.0M
$56.0M
$55.0M
$56.0M
$60.0M
$64.0M
$61.0M
$64.0M
$67.0M
$70.0M
$68.0M
Operating Expenses
$39.0M
$42.0M
$41.0M
$42.0M
$43.0M
$47.0M
$48.0M
$41.0M
$46.0M
$49.0M
$50.0M
$50.0M
Operating Profit
$10.0M
$12.0M
$14.0M
$13.0M
$13.0M
$13.0M
$16.0M
$20.0M
$19.0M
$18.0M
$20.0M
$18.0M
Operating Margin
20.9%
22.2%
25.8%
24.0%
23.1%
21.1%
25.1%
33.3%
29.2%
26.7%
29.0%
26.0%
Interest
$0
$0
$0
$0
$0
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
$1.0M
Profit Before Tax
$11.0M
$13.0M
$16.0M
$15.0M
$14.0M
$14.0M
$18.0M
$23.0M
$20.0M
$20.0M
$22.0M
$20.0M
Tax rate (%)
25.2%
22.7%
23.7%
23.4%
20.2%
22.7%
23.8%
23.1%
23.2%
20.3%
23.2%
23.6%
Net Profit
$8.0M
$10.0M
$12.0M
$11.0M
$11.0M
$11.0M
$14.0M
$17.0M
$16.0M
$16.0M
$17.0M
$15.0M
EPS
$0.38
$0.43
$0.52
$0.49
$0.49
$0.48
$0.60
$0.75
$0.68
$0.68
$0.74
$0.65
Over the 10 years reported for LeMaitre Vascular, Inc., cash stood at $28.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 13.00 times.
Balance Sheet — 10 Years (USD millions)
Metric
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
$102.0M
$126.0M
$153.0M
$188.0M
$253.0M
$293.0M
$310.0M
$347.0M
$552.0M
$616.0M
Current Assets
$59.0M
$80.0M
$94.0M
$92.0M
$94.0M
$140.0M
$162.0M
$195.0M
$402.0M
$468.0M
Cash
$24.0M
$19.0M
$26.0M
$12.0M
$27.0M
$14.0M
$19.0M
$24.0M
$26.0M
$28.0M
Inventory
$20.0M
$21.0M
$26.0M
$35.0M
$39.0M
$41.0M
$45.0M
$52.0M
$56.0M
$70.0M
Receivables
$13.0M
$15.0M
$16.0M
$17.0M
$20.0M
$20.0M
$22.0M
$25.0M
$30.0M
$34.0M
Fixed Assets
$8.0M
$12.0M
$14.0M
$30.0M
$31.0M
$32.0M
$34.0M
$40.0M
$42.0M
$43.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$0
$23.0M
$22.0M
$21.0M
$0
$56.0M
$64.0M
$81.0M
$274.0M
$331.0M
Other Assets
$23.0M
$24.0M
$30.0M
$40.0M
$66.0M
$66.0M
$66.0M
$66.0M
$66.0M
$66.0M
Total Liabilities
$14.0M
$17.0M
$23.0M
$40.0M
$80.0M
$39.0M
$42.0M
$49.0M
$215.0M
$222.0M
Current Liabilities
$10.0M
$13.0M
$20.0M
$21.0M
$25.0M
$22.0M
$25.0M
$30.0M
$31.0M
$36.0M
Borrowings
$0
$0
$0
$16.0M
$55.0M
$16.0M
$17.0M
$19.0M
$186.0M
$186.0M
Other Liabilities
$14.0M
$17.0M
$23.0M
$24.0M
$25.0M
$23.0M
$26.0M
$30.0M
$29.0M
$37.0M
Equity
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Reserves
$88.0M
$110.0M
$130.0M
$148.0M
$173.0M
$254.0M
$268.0M
$298.0M
$337.0M
$394.0M
For LeMaitre Vascular, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $74.0M; free cash flow was positive in 10 of 10 years; financing activities used $3.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 10 Years (USD millions)
Metric
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating Cash Flow
$17.0M
$23.0M
$20.0M
$14.0M
$35.0M
$35.0M
$25.0M
$37.0M
$44.0M
$81.0M
Investing Cash Flow
−$20.0M
−$58.0M
−$2.0M
−$28.0M
−$56.0M
−$66.0M
−$14.0M
−$32.0M
−$207.0M
−$72.0M
Financing Cash Flow
−$1.0M
−$1.0M
−$2.0M
−$3.0M
−$5.0M
−$1.0M
−$2.0M
−$1.0M
−$3.0M
−$3.0M
Net Cash Flow
−$3.0M
−$5.0M
$7.0M
−$15.0M
$15.0M
−$13.0M
$5.0M
$5.0M
$1.0M
$3.0M
Free Cash Flow
$14.0M
$16.0M
$16.0M
$10.0M
$32.0M
$30.0M
$22.0M
$29.0M
$37.0M
$74.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
1.57
EV / EBITDA
21.15
FCF Yield
3.77%
Quick Ratio
12.54
Interest Coverage
14.35
Return 1Y
-11.78%
Return 3Y
54.60%
Return 5Y
52.76%
LeMaitre Vascular, Inc. (LMAT) financials — frequently asked questions
What is LeMaitre Vascular, Inc.'s annual revenue?
LeMaitre Vascular, Inc. (LMAT) reported annual revenue of $250.0M in its most recent fiscal year.
What is LeMaitre Vascular, Inc.'s net profit?
LeMaitre Vascular, Inc. (LMAT) reported net profit of $58.0M in its most recent fiscal year.
What is LMAT EV/EBITDA?
LeMaitre Vascular, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 21.15.
Revenue and earnings of other Medical - Instruments & Supplies stocks